| Y20170001735 | 重酒石酸卡巴拉汀 | Rivastigmine Hydrogen Tartrate | Active ingredient | Other | Other | 2018-07-27 | | Langfang Gaobo Jingband Pharmaceutical Co Ltd | | | view |
| JYHZ2200076 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2022-03-10 | | | | | view |
| JYHZ2200075 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2022-03-10 | | | | | view |
| JYHZ2200074 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2022-03-10 | | | | | view |
| JYHZ2100741 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2021-12-22 | | | | | view |
| JYHZ2100740 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2021-12-22 | | | | | view |
| JYHZ1700218 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2017-07-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2018-10-31 | view |
| JYHZ1700217 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2017-07-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2018-10-31 | view |
| JYHZ1700216 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | License Renew | 2017-07-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2018-10-31 | view |
| JYHB2300479 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2023-08-26 | | | | | view |
| JYHB2300478 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2023-08-26 | | | | | view |
| JYHB2300477 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2023-08-26 | | | | | view |
| JYHB2250002 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2022-06-28 | | Sun Pharmaceutical Industries Ltd | | | view |
| JYHB2250001 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2022-06-28 | | Sun Pharmaceutical Industries Ltd | | | view |
| JYHB2200638 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2022-11-17 | | | | | view |
| JYHB2200637 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2022-11-17 | | | | | view |
| JYHB2200636 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2022-11-17 | | | | | view |
| JYHB2050002 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2020-04-07 | 印度太阳药业有限公司上海代表处 | India Sun Pharmaceutical Co Ltd Shanghai Representative Office | In Review | 2020-04-04 | view |
| JYHB2050001 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2020-04-07 | 印度太阳药业有限公司上海代表处 | India Sun Pharmaceutical Co Ltd Shanghai Representative Office | In Review | 2020-04-04 | view |
| JYHB2002458 | 重酒石酸卡巴拉汀胶囊 | Rivastigmine Hydrogen Tartrate | Capsule | Chemical Drugs | Supplementary Application | 2020-12-02 | 诺思格（北京）医药科技股份有限公司 | R&G PharmaStudies Co Ltd | Filed | 2020-12-10 | view |
